News Releases

Feb 15, 2023
Axcella Announces FDA IND Clearance Supporting Regulatory Path to Registration of AXA1125 for Long COVID Fatigue
Feb 09, 2023
Axcella Therapeutics to Participate in the SVB Securities’ 2023 Global Biopharma Conference
Jan 23, 2023
Axcella Announces Regulatory Path to Registration of AXA1125 for Long COVID Fatigue